What is the ticker symbol for HCW Biologics?

HCW Biologics trades under the ticker HCWB on NASDAQ.

What sector does HCW Biologics operate in?

HCW Biologics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze HCWB in a portfolio?

PortView shows HCWB's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

HCW Biologics (HCWB) Stock Analysis

NASDAQHealthcareBiotechnology

$3.41-1.21%

1-year price historyRange $1.61 – $33.54

52-week range$3.41

$1.50$36.65

What HCW Biologics does

HCW Biologics Inc. operates as a preclinical-stage biopharmaceutical firm, primarily engaged in the discovery and advancement of novel immunotherapies. Its research and development efforts are focused on addressing chronic, low-grade inflammation and a spectrum of age-related diseases. The company's leading therapeutic candidates include HCW9218, an injectable immunotherapeutic designed for patients with a variety of cancers, such as pancreatic, ovarian, breast, prostate, and colorectal, as well as for pulmonary fibrosis. Another key product, HCW9302, targets autoimmune conditions like alopecia areata and various metabolic disorders. Beyond these, HCW Biologics is also developing HCW9201, a cell-based therapy currently in Phase II clinical trials for the treatment of relapsed/refractory acute myeloid leukemia. Additionally, HCW9206 is under development specifically for acute myeloid leukemia. Incorporated in 2018, the company's corporate headquarters are situated in Miramar, Florida.

Key metrics

Market cap

$1.18M

P/E (TTM)

-0.08

EPS (TTM)

$-45.28

Beta

2.36

Dividend yield

0.00%

Revenue / share

$19.22

50-day avg

$3.68

200-day avg

$5.96

52-week high

$36.65

52-week low

$1.50

CEO

Hing C. Wong

ETFs linked to HCWB

Broad-market and Healthcare sector ETFs an investor holding HCW Biologics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how HCWB fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze HCWB in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for HCW Biologics?: HCW Biologics trades under the ticker HCWB on NASDAQ.
Which exchange is HCWB listed on?: HCWB is listed on NASDAQ.
What sector does HCW Biologics operate in?: HCW Biologics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze HCWB in a portfolio?: PortView shows HCWB's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.